76757-90-9Relevant articles and documents
Synthesis, docking study and inhibitory activity of 2,6-diketopiperazines derived from α-amino acids on HDAC8
Garrido González, Flor Paulina,Mancilla Percino, Teresa
supporting information, (2020/07/21)
Diketopiperazines (DKPs) have been regarded as an important scaffold from the viewpoint of synthesis due to their biological properties for the treatment of several diseases, including cancer. In this work, two novel series of enantiomeric 2,6-DKPs derived from α-amino acids were synthesized through nucleophilic substitution and intramolecular cyclization reactions. All the compounds were docked against histone deacetylase 8 (HDAC8), which is a promising target for the development of anticancer drugs. These compounds bound into the active site of HDAC8 in a similar way to Trichostatin A (TSA), which is an HDAC8 inhibitor. This study showed that the conformation of the 2,6-DKP ring, stereochemistry, and the type of substituent on the chiral center had an important role in the binding modes. The Gibbs free energies and dissociation constants values of HDAC8-ligand complexes showed that compounds (S)-4hBn, (S)-4m, (R)-4h, and (R)-4m were more stable and affine towards HDAC8 than TSA. The inhibitory activities of 4a, (S)-4h, (S)- and (R)-4(g, l, m) were evaluated in vitro on HDAC8. It was found that compounds (R)-4g (IC50 = 21.54 nM) and (R)-4m (IC50 = 10.81 nM) exhibited better inhibitory activities than TSA (IC50 = 28.32 nM). These results suggested that 2,6-DKPs derivatives may be promising anticancer agents for further biological studies.
Synthesis and Biological Evaluation of Modified Miuraenamides
Kappler, Sarah,Karmann, Lisa,Prudel, Cynthia,Herrmann, Jennifer,Caddeu, Giulia,Müller, Rolf,Vollmar, Angelika M.,Zahler, Stefan,Kazmaier, Uli
, p. 6952 - 6965 (2018/11/25)
Miuraenamides, secondary metabolites of the marine myxobacterium Paraliomyxa miuraensis do not only show a high structural similarity to other cyclodepsipeptides isolated from sponges or terrestrial myxobacteria but they also exhibit a similar mode of act
Method for preparing alanine derivative
-
Paragraph 0114; 0115; 0116, (2016/10/10)
The invention discloses a method for preparing an alanine derivative represented by a formula (I) shown in the description. The alanine derivative can serve as synthesis intermediates of opium receptor regulators, such as a synthesis intermediate of eluxadoline. According to the method, chiral tyrosine which is cheap and readily available serves as an initial raw material, a bran-new synthesis route for preparing the alanine derivative is provided, the total yield of the entire reaction route is high, the cost is low, the reaction conditions are mild, and the operation is simple and safe, so that the method is applicable to large-scale industrial production.